Jazz Pharmaceuticals plc (NASDAQ: JAZZ) filed an order in New Jersey’s District Court stating that it had dismissed the last of the patent claims against the company’s cannabis epilepsy drug Epidiolex. Jazz acquired the company GW Pharmaceuticals which had developed Epidiolex for the treatment of rare pediatric epilepsy conditions Dravet… …